Egon Willighagen
Overview
Explore the profile of Egon Willighagen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
1148
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kienhuis A, Krul C, van Engelen J, Evelo C, Hessel E, Hoekman J, et al.
ALTEX
. 2024 Oct;
42(1):111-120.
PMID: 39396389
The Virtual Human Platform for Safety Assessment (VHP4Safety) project aims to build a virtual human platform (VHP) to protect human health and revolutionize the safety assessment of chemicals and pharmaceuticals...
2.
Groenewold M, Bleeker E, Noorlander C, Sips A, van der Zee M, Aitken R, et al.
NanoImpact
. 2024 May;
35:100513.
PMID: 38821170
The past few decades of managing the uncertain risks associated with nanomaterials have provided valuable insights (knowledge gaps, tools, methods, etc.) that are equally important to promote safe and sustainable...
3.
Jeliazkova N, Longhin E, El Yamani N, Runden-Pran E, Moschini E, Serchi T, et al.
Nat Protoc
. 2024 May;
19(9):2642-2684.
PMID: 38755447
Making research data findable, accessible, interoperable and reusable (FAIR) is typically hampered by a lack of skills in technical aspects of data management by data generators and a lack of...
4.
Ammar A, Evelo C, Willighagen E
Sci Data
. 2024 May;
11(1):503.
PMID: 38755173
Nanomaterials hold great promise for improving our society, and it is crucial to understand their effects on biological systems in order to enhance their properties and ensure their safety. However,...
5.
Furxhi I, Willighagen E, Evelo C, Costa A, Gardini D, Ammar A
NanoImpact
. 2023 Jul;
31:100475.
PMID: 37423508
Introduction: The current effort towards the digital transformation across multiple scientific domains requires data that is Findable, Accessible, Interoperable and Reusable (FAIR). In addition to the FAIR data, what is...
6.
Rocca-Serra P, Gu W, Ioannidis V, Abbassi-Daloii T, Capella-Gutierrez S, Chandramouliswaran I, et al.
Sci Data
. 2023 May;
10(1):292.
PMID: 37208467
The notion that data should be Findable, Accessible, Interoperable and Reusable, according to the FAIR Principles, has become a global norm for good data stewardship and a prerequisite for reproducibility....
7.
Ammar A, Cavill R, Evelo C, Willighagen E
J Cheminform
. 2023 Mar;
15(1):31.
PMID: 36864534
Protein mutations, especially those which occur in the binding site, play an important role in inter-individual drug response and may alter binding affinity and thus impact the drug's efficacy and...
8.
Willighagen E
J Cheminform
. 2023 Feb;
15(1):14.
PMID: 36737837
Citations are an essential aspect of research communication and have become the basis of many evaluation metrics in the academic world. Some see citation counts as a mark of scientific...
9.
Hoyt C, Balk M, Callahan T, Domingo-Fernandez D, Haendel M, Hegde H, et al.
Sci Data
. 2022 Nov;
9(1):714.
PMID: 36402838
The standardized identification of biomedical entities is a cornerstone of interoperability, reuse, and data integration in the life sciences. Several registries have been developed to catalog resources maintaining identifiers for...
10.
van Rijn J, Afantitis A, Culha M, Dusinska M, Exner T, Jeliazkova N, et al.
J Cheminform
. 2022 Aug;
14(1):57.
PMID: 36002868
Management of nanomaterials and nanosafety data needs to operate under the FAIR (findability, accessibility, interoperability, and reusability) principles and this requires a unique, global identifier for each nanomaterial. Existing identifiers...